MedTech Terms
    The authoritative reference
    Back to Risk & Usability Deep Dive
    Clinical & TrialsClinical EvidenceStartup LifecycleHFE

    Human Factors Engineering

    Engineering discipline focused on safe and effective device use by intended users.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Human Factors Engineering (also called Usability Engineering) applies knowledge of human behavior, abilities, and limitations to the design of medical devices to ensure safe and effective use by intended users in intended use environments. FDA's 2016 guidance on applying human factors and usability engineering expects manufacturers to identify critical tasks, design out use-related hazards, and run a summative (validation) test with representative users in realistic conditions. Results feed the risk file under ISO 14971 and the usability engineering file under IEC 62366-1, and human factors data is expected in many 510(k), De Novo and PMA submissions.
    What the regulation says
    FDA’s guidance Applying Human Factors and Usability Engineering to Medical Devices, issued February 3, 2016, recommends a risk-based approach to safe and effective device use. Manufacturers should identify critical tasks, prioritize design changes that reduce use-related hazards, and validate the final user interface with representative users under realistic conditions. Validation should examine use errors, close calls, and difficulties, including their causes and potential consequences. The guidance is nonbinding, and submission expectations depend on the device and its use-related risks. Human factors evidence can support 510(k), De Novo, and PMA submissions; validation is not necessarily a clinical trial. For MedTech manufacturers, binding quality-system requirements sit in 21 CFR Part 820. FDA’s Quality Management System Regulation, effective February 2, 2026, incorporates ISO 13485:2016, including applicable design and development requirements. ISO 14971:2019 and IEC 62366-1:2015, amended in 2020, provide complementary risk-management and usability-engineering frameworks, rather than standalone legal obligations everywhere. In the EU, Regulation (EU) 2017/745, applicable from May 26, 2021, expressly addresses use-related safety: Annex I, Section 5 requires manufacturers to reduce risks associated with ergonomic features and the intended use environment, and to consider intended users’ knowledge, experience, training, and physical condition.

    What this means in practice

    FDA expects a Human Factors Validation Study for devices with use-related risks. Findings can drive labeling, training, and design changes.

    Examples

    • During formative testing of an infusion pump, nurses confuse dose units on the programming screen. The team revises the display and later evaluates safe dose programming in validation testing under realistic ward conditions.
    • A home injection device is evaluated with patients who have limited hand dexterity. Participants demonstrate preparation, injection, and disposal using the proposed instructions, helping assess whether critical tasks can be completed safely.
    • A bedside monitor’s alarm controls are tested with representative clinical staff in a simulated care environment. Investigators examine whether users distinguish silencing an alarm from disabling monitoring and investigate any errors before finalizing the interface.

    Use cases

    1 scenario
    1

    Auto-injector for at-home use

    Human factors engineer

    The team performs formative studies with caregivers and patients, identifies confusion around the safety cap, redesigns it, then runs a validation study with 15 users per use group per IEC 62366-1 and FDA HF guidance.

    OutcomeUse-error rates drop to acceptable thresholds; the HF validation report supports the 510(k) and PMS plan.
    Common pitfalls
    • •Treating human factors validation as a satisfaction survey. It evaluates safe and effective performance of critical tasks, not just whether users like the device.
    • •Relying on warnings or training instead of addressing avoidable interface hazards. Design changes should be considered before relying on users to remember instructions.
    • •Testing only with employees or experienced clinicians in ideal conditions. Participants and conditions should represent intended users, including lay users where applicable, and intended use environments.

    Frequently asked questions

    Formative usability studies are conducted iteratively during design to identify use errors and refine the user interface, and they are expected practice but not separately mandated by regulation. A summative Human Factors Validation Study is required before submission for devices where use-related risks could result in serious harm, per FDA's Applying Human Factors and Usability Engineering to Medical Devices guidance, and it must test the final labeling, training materials, and user interface with representative users performing critical tasks. Skipping straight to summative testing without formative iterations is a common reviewer objection because it suggests use errors were not designed out before validation.

    Cross-references

    See also

    Related terms

    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Learning paths (1)

    Latest in MedTech

    Sources

    3 sources

    Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 2Regulator guidance and consensus· 2Tier 3Peer-reviewed and registry evidence· 1
    Link health: 3 verified· last checked 2026-06-20
    FDA·1NIH·1ICH·1
    1. 1
      FDA Human Factors Guidance
      Tier 2 Verified
      FDAfda.gov
    2. 2
      ClinicalTrials.gov
      Tier 3 Verified
      NIHclinicaltrials.gov
    3. 3
      ICH Guidelines
      Tier 2 Verified
      ICHich.org

    Inline markers like [1] jump to the matching reference above.